Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
QuintilesIMS
Farmers Insurance
Harvard Business School
Medtronic
AstraZeneca
Healthtrust
Argus Health
Cerilliant

Generated: November 15, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Crenezumab

« Back to Dashboard

US Patents for Crenezumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Crenezumab ➤ Try a Free Trial Method and composition for hyperthermally treating cells ➤ Try a Free Trial
Crenezumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Crenezumab ➤ Try a Free Trial Detection of misfolded amyloid beta protein AMPRION, INC. (San Diego, CA) THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, TX) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Crenezumab

Drugname Country Document Number Estimated Expiration Related US Patent
Crenezumab European Patent Office 2736437 2022-02-14 ➤ Try a Free Trial
Crenezumab World Intellectual Property Organization (WIPO) 2013015959 2022-02-14 ➤ Try a Free Trial
Crenezumab World Intellectual Property Organization (WIPO) 2013081928 2022-02-14 ➤ Try a Free Trial
Crenezumab Australia 2013220749 2032-02-15 ➤ Try a Free Trial
Crenezumab Brazil 112014019627 2032-02-15 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Healthtrust
UBS
Chubb
QuintilesIMS
US Army
Fish and Richardson
Cipla
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.